EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery

Brett L Houston iD, Daniel I McIsaac, Rodney H Breau, Salmaan Kanji, Peter Greenstreet, Meghan Andrews, Sinziana Avramescu, Hema S Bagry, Robert Balshaw, Jayesh Daya, Kaitlin Duncan, Christopher C Harle und 16 weitere

New England Journal of Medicine · 2026

DOI: 10.1056/nejmoa2515820 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift New England Journal of Medicine, 2026. Verfasst von Brett L Houston und 27 weiteren Autor:innen. Beteiligte Einrichtung: University of Manitoba, Winnipeg, Canada. Hauptthemen laut MEDLINE: Antifibrinolytic Agents, Blood Loss, Surgical, Erythrocyte Transfusion, Surgical Procedures, Operative. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Ontario Ministry of Health and Long-Term Care, CIHR, Ontario Ministry of Health Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifibrinolytic AgentsBlood Loss, SurgicalErythrocyte TransfusionSurgical Procedures, OperativeTranexamic AcidAgedFemaleHumansMaleMiddle AgedCross-Over StudiesDouble-Blind MethodIntraoperative CareVenous ThromboembolismCanadaHospitalizationFollow-Up Studies

Substanzen

Antifibrinolytic AgentsTranexamic Acid

Autor:innen und Institutionen

  • University of Manitoba, Winnipeg, Canada.
  • CancerCare Manitoba, Winnipeg, Canada.
  • University of Ottawa, Ottawa.
  • Ottawa Hospital Research Institute, Ottawa.
  • Institute for Clinical Evaluative Sciences (ICES), Ottawa.
  • Montfort Institut du Savoir, Ottawa.

ORCID-Profile: Brett L Houston

Förderung

  • Ontario Ministry of Health and Long-Term Care
  • CIHR
  • Ontario Ministry of Health Innovation Fund
  • Health Sciences Center Foundation
  • CIHR Rewarding Success Operating Grant
  • Government of Manitoba through the Ministry of Health, Seniors and Long-Term Care
  • Canadian Institutes of Health Research (CIHR) Catalyst Grant: Supporting Patient Oriented Research (SPOR) Innovative Clinical Trials

Zitieren

APA

Houston, B. L., McIsaac, D. I., Breau, R. H., Kanji, S., Greenstreet, P., Andrews, M., Avramescu, S., Bagry, H. S., Balshaw, R., Daya, J., Duncan, K., Harle, C. C., Jacobsohn, E., Kerelska, T., Pitz, M., Komenda, P., McIsaac, S., Ramsay, T., Saha, T., …, & Zarychanski, R. (2026). Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2515820

Vancouver

Houston BL, McIsaac DI, Breau RH, Kanji S, Greenstreet P, Andrews M, et al. Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2515820

BibTeX
@article{Houston2026,
  author = {Houston, Brett L and McIsaac, Daniel I and Breau, Rodney H and Kanji, Salmaan and Greenstreet, Peter and Andrews, Meghan and Avramescu, Sinziana and Bagry, Hema S and Balshaw, Robert and Daya, Jayesh and Duncan, Kaitlin and Harle, Christopher C and Jacobsohn, Eric and Kerelska, Tina and Pitz, Marshall and Komenda, Paul and McIsaac, Sarah and Ramsay, Tim and Saha, Tarit and Tinmouth, Alan and Recio, Angela and Szoke, Daniel and Tenenbein, Marshall and Slagerman, Sarah and Solvason, Dayna and Talarico, Robert and Fergusson, Dean A and Zarychanski, Ryan},
  title = {Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery},
  journal = {New England Journal of Medicine},
  year = {2026},
  doi = {10.1056/nejmoa2515820}
}
Kostenlos starten →